{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T23:12:04Z","timestamp":1793315524010,"version":"4.5.0"},"reference-count":140,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,7,19]],"date-time":"2023-07-19T00:00:00Z","timestamp":1689724800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100003009","name":"Science and Technology Development Fund","doi-asserted-by":"publisher","award":["0075\/2019\/AMJ"],"award-info":[{"award-number":["0075\/2019\/AMJ"]}],"id":[{"id":"10.13039\/501100003009","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biomedicine &amp; Pharmacotherapy"],"published-print":{"date-parts":[[2023,9]]},"DOI":"10.1016\/j.biopha.2023.115198","type":"journal-article","created":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T12:43:31Z","timestamp":1690893811000},"page":"115198","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":13,"special_numbering":"C","title":["Targeting abnormal lipid metabolism of T cells for systemic lupus erythematosus treatment"],"prefix":"10.1016","volume":"165","author":[{"given":"Jia-Qin","family":"Hu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan-Hua","family":"Yan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Han","family":"Xie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xue-Bing","family":"Feng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei-Hong","family":"Ge","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hua","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li-Li","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ling-Yun","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ying","family":"Xie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"9","key":"10.1016\/j.biopha.2023.115198_bib1","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1038\/s41584-021-00668-1","article-title":"Global epidemiology of systemic lupus erythematosus","volume":"17","author":"Barber","year":"2021","journal-title":"Nat. Rev. Rheumatol."},{"issue":"3","key":"10.1016\/j.biopha.2023.115198_bib2","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1136\/ard-2022-223035","article-title":"Global epidemiology of systemic lupus erythematosus: a comprehensive systematic analysis and modelling study","volume":"82","author":"Tian","year":"2023","journal-title":"Ann. Rheum. Dis."},{"issue":"10","key":"10.1016\/j.biopha.2023.115198_bib3","article-title":"An overview of systemic lupus erythematosus (SLE) pathogenesis, classification, and management","volume":"14","author":"Ameer","year":"2022","journal-title":"Cureus"},{"key":"10.1016\/j.biopha.2023.115198_bib4","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jaut.2018.11.001","article-title":"Systemic lupus erythematosus: diagnosis and clinical management","volume":"96","author":"Fava","year":"2019","journal-title":"J. Autoimmun."},{"issue":"3","key":"10.1016\/j.biopha.2023.115198_bib5","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1007\/s40744-020-00212-9","article-title":"Systemic lupus erythematosus (SLE) therapy: the old and the new","volume":"7","author":"Basta","year":"2020","journal-title":"Rheuma Ther."},{"issue":"2","key":"10.1016\/j.biopha.2023.115198_bib6","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1007\/s12026-016-8892-9","article-title":"Dyslipidemia in systemic lupus erythematosus","volume":"65","author":"Szab\u00f3","year":"2017","journal-title":"Immunol. Res"},{"issue":"6","key":"10.1016\/j.biopha.2023.115198_bib7","doi-asserted-by":"crossref","first-page":"1539","DOI":"10.1007\/s10067-018-4051-0","article-title":"Clinical and laboratory aspects of dyslipidemia in Brazilian women with systemic lupus erythematosus","volume":"37","author":"Atta","year":"2018","journal-title":"Clin. Rheuma"},{"issue":"4","key":"10.1016\/j.biopha.2023.115198_bib8","doi-asserted-by":"crossref","first-page":"1283","DOI":"10.1002\/art.21748","article-title":"The complex nature of the interaction between disease activity and therapy on the lipid profile in patients with pediatric systemic lupus erythematosus","volume":"54","author":"Sarkissian","year":"2006","journal-title":"Arthritis Rheum."},{"issue":"2","key":"10.1016\/j.biopha.2023.115198_bib9","doi-asserted-by":"crossref","DOI":"10.20900\/immunometab20200009","article-title":"T cell Metabolism in Lupus","volume":"2","author":"Vukelic","year":"2020","journal-title":"Immunometabolism"},{"issue":"2","key":"10.1016\/j.biopha.2023.115198_bib10","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1038\/s41584-019-0356-x","article-title":"T cell metabolism: new insights in systemic lupus erythematosus pathogenesis and therapy","volume":"16","author":"Sharabi","year":"2020","journal-title":"Nat. Rev. Rheuma"},{"issue":"6","key":"10.1016\/j.biopha.2023.115198_bib11","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1097\/BOR.0000000000000815","article-title":"The role of CD8+ T-cell systemic lupus erythematosus pathogenesis: an update","volume":"33","author":"Chen","year":"2021","journal-title":"Curr. Opin. Rheuma"},{"issue":"3","key":"10.1016\/j.biopha.2023.115198_bib12","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1016\/j.rdc.2021.04.005","article-title":"T cells in systemic lupus erythematosus","volume":"47","author":"Paredes","year":"2021","journal-title":"Rheum. Dis. Clin. North Am."},{"issue":"5","key":"10.1016\/j.biopha.2023.115198_bib13","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1038\/s41589-022-01017-3","article-title":"Lipid metabolism in T cell signaling and function","volume":"18","author":"Lim","year":"2022","journal-title":"Nat. Chem. Biol."},{"issue":"5","key":"10.1016\/j.biopha.2023.115198_bib14","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1038\/cmi.2015.89","article-title":"The regulation of the Treg\/Th17 balance by mesenchymal stem cells in human systemic lupus erythematosus","volume":"14","author":"Wang","year":"2017","journal-title":"Cell Mol. Immunol."},{"key":"10.1016\/j.biopha.2023.115198_bib15","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2021.105747","article-title":"Liver X receptors conserve the therapeutic target potential for the treatment of rheumatoid arthritis","volume":"170","author":"Mai","year":"2021","journal-title":"Pharmacol. Res."},{"issue":"5","key":"10.1016\/j.biopha.2023.115198_bib16","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1089\/ars.2017.7090","article-title":"Suppression of lipogenesis via reactive oxygen species-AMPK signaling for treating malignant and proliferative diseases","volume":"28","author":"Fan","year":"2018","journal-title":"Antioxid. Redox Signal"},{"key":"10.1016\/j.biopha.2023.115198_bib17","article-title":"Lipid metabolism: immune regulation and therapeutic prospectives in systemic lupus erythematosus","volume":"13","author":"Sun","year":"2022","journal-title":"Front Immunol."},{"issue":"159","key":"10.1016\/j.biopha.2023.115198_bib18","first-page":"49","article-title":"Role of dyslipidemia in accelerating inflammation, autoimmunity, and atherosclerosis in systemic lupus erythematosus and other autoimmune diseases","volume":"30","author":"Wang","year":"2020","journal-title":"Discov. Med"},{"issue":"6","key":"10.1016\/j.biopha.2023.115198_bib19","doi-asserted-by":"crossref","first-page":"1402","DOI":"10.1681\/ASN.2014050508","article-title":"Renal glycosphingolipid metabolism is dysfunctional in lupus nephritis","volume":"26","author":"Nowling","year":"2015","journal-title":"J. Am. Soc. Nephrol."},{"issue":"2","key":"10.1016\/j.biopha.2023.115198_bib20","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1002\/art.23353","article-title":"Accumulation of coronary artery disease risk factors over three years: data from an international inception cohort","volume":"59","author":"Urowitz","year":"2008","journal-title":"Arthritis Rheum."},{"issue":"3","key":"10.1016\/j.biopha.2023.115198_bib21","first-page":"132","article-title":"The proportion of dyslipidemia in systemic lupus erythematosus patient and distribution of correlated factors","volume":"37","author":"Wijaya","year":"2005","journal-title":"Acta Med Indones."},{"issue":"3","key":"10.1016\/j.biopha.2023.115198_bib22","doi-asserted-by":"crossref","DOI":"10.3390\/biom13030401","article-title":"Role of altered metabolism of triglyceride-rich lipoprotein particles in the development of vascular dysfunction in systemic lupus erythematosus","volume":"13","author":"Di\u00f3szegi","year":"2023","journal-title":"Biomolecules"},{"issue":"6","key":"10.1016\/j.biopha.2023.115198_bib23","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1177\/096120339700600610","article-title":"Dyslipoproteinemias in systemic lupus erythematosus: influence of disease, activity, and anticardiolipin antibodies","volume":"6","author":"Borba","year":"1997","journal-title":"Lupus"},{"key":"10.1016\/j.biopha.2023.115198_bib24","doi-asserted-by":"crossref","first-page":"1023651","DOI":"10.3389\/fcvm.2022.1023651","article-title":"Oxidized low-density lipoprotein associates with cardiovascular disease by a vicious cycle of atherosclerosis and inflammation: a systematic review and meta-analysis","volume":"9","author":"Hong","year":"2022","journal-title":"Front Cardiovasc Med"},{"key":"10.1016\/j.biopha.2023.115198_bib25","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jnutbio.2015.11.002","article-title":"Role of lipids in the metabolism and activation of immune cells","volume":"34","author":"Hubler","year":"2016","journal-title":"J. Nutr. Biochem"},{"issue":"1","key":"10.1016\/j.biopha.2023.115198_bib26","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1080\/09687860500453673","article-title":"Lipid rafts in T cell receptor signalling","volume":"23","author":"Kabouridis","year":"2006","journal-title":"Mol. Membr. Biol."},{"key":"10.1016\/j.biopha.2023.115198_bib27","doi-asserted-by":"crossref","first-page":"1636","DOI":"10.3389\/fimmu.2017.01636","article-title":"Transcriptional regulation of T-cell lipid metabolism: implications for plasma membrane lipid rafts and T-cell function","volume":"8","author":"Robinson","year":"2017","journal-title":"Front Immunol."},{"issue":"2","key":"10.1016\/j.biopha.2023.115198_bib28","doi-asserted-by":"crossref","first-page":"712","DOI":"10.1172\/JCI69571","article-title":"Normalizing glycosphingolipids restores function in CD4+ T cells from lupus patients","volume":"124","author":"McDonald","year":"2014","journal-title":"J. Clinical Investig."},{"issue":"23","key":"10.1016\/j.biopha.2023.115198_bib29","doi-asserted-by":"crossref","first-page":"3921","DOI":"10.1002\/1873-3468.13275","article-title":"The regulatory roles of glycosphingolipid-enriched lipid rafts in immune systems","volume":"592","author":"Nakayama","year":"2018","journal-title":"FEBS Lett."},{"issue":"2","key":"10.1016\/j.biopha.2023.115198_bib30","doi-asserted-by":"crossref","DOI":"10.1084\/jem.20201966","article-title":"TCR signal strength defines distinct mechanisms of T cell dysfunction and cancer evasion","volume":"219","author":"Shakiba","year":"2022","journal-title":"J. Exp. Med"},{"issue":"2","key":"10.1016\/j.biopha.2023.115198_bib31","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1111\/j.1365-2249.2010.04245.x","article-title":"Impact of Fli-1 transcription factor on autoantibody and lupus nephritis in NZM2410 mice","volume":"162","author":"Mathenia","year":"2010","journal-title":"Clinical Exp. Immunol."},{"key":"10.1016\/j.biopha.2023.115198_bib32","doi-asserted-by":"crossref","unstructured":"K.E. Waddington, G.A. Robinson, B. Rubio-Cuesta, E. Chrifi-Alaoui, S. Andreone, K.-S. Poon, I. Ivanova, L. Martin-Gutierrez, D.M. Owen, E.C. Jury, I. Pineda-Torra, LXR directly regulates glycosphingolipid synthesis and affects human CD4+ T cell function, Proceedings of the National Academy of Sciences 118(21) (2021) e2017394118.","DOI":"10.1073\/pnas.2017394118"},{"issue":"3","key":"10.1016\/j.biopha.2023.115198_bib33","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0230499","article-title":"Targeting glycosphingolipid metabolism as a potential therapeutic approach for treating disease in female MRL\/lpr lupus mice","volume":"15","author":"Nowling","year":"2020","journal-title":"PLoS One"},{"issue":"21","key":"10.1016\/j.biopha.2023.115198_bib34","doi-asserted-by":"crossref","DOI":"10.1172\/JCI143950","article-title":"The druggable transcription factor Fli-1 regulates T cell immunity and tolerance in graft-versus-host disease","volume":"132","author":"Schutt","year":"2022","journal-title":"J. Clinical Investig."},{"issue":"21","key":"10.1016\/j.biopha.2023.115198_bib35","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2017394118","article-title":"LXR directly regulates glycosphingolipid synthesis and affects human CD4+ T cell function","volume":"118","author":"Waddington","year":"2021","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"1","key":"10.1016\/j.biopha.2023.115198_bib36","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1080\/10408398.2020.1854675","article-title":"The role of short-chain fatty acids in immunity, inflammation and metabolism","volume":"62","author":"Yao","year":"2022","journal-title":"Crit. Rev. Food Sci. Nutr."},{"issue":"4","key":"10.1016\/j.biopha.2023.115198_bib37","doi-asserted-by":"crossref","DOI":"10.1084\/jem.20201311","article-title":"Nuclear receptor LXR\u03b2 controls fitness and functionality of activated T cells","volume":"218","author":"Michaels","year":"2021","journal-title":"J. Exp. Med"},{"issue":"2","key":"10.1016\/j.biopha.2023.115198_bib38","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1073\/pnas.1812186116","article-title":"Differential control of human Treg and effector T cells in tumor immunity by Fc-engineered anti-CTLA-4 antibody","volume":"116","author":"Ha","year":"2019","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"4","key":"10.1016\/j.biopha.2023.115198_bib39","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1016\/j.reuma.2022.05.001","article-title":"Relative CTLA-4, PTPN-22, and interleukin 37 mRNA expressions in patients with lupus nephritis","volume":"19","author":"Moneim","year":"2023","journal-title":"Reumatol. Cl\u00ednica"},{"issue":"7","key":"10.1016\/j.biopha.2023.115198_bib40","doi-asserted-by":"crossref","DOI":"10.1084\/jem.20221391","article-title":"CTLA4 depletes T cell endogenous and trogocytosed B7 ligands via cis-endocytosis","volume":"220","author":"Xu","year":"2023","journal-title":"J. Exp. Med"},{"issue":"1","key":"10.1016\/j.biopha.2023.115198_bib41","doi-asserted-by":"crossref","first-page":"4","DOI":"10.55563\/clinexprheumatol\/nolysy","article-title":"One year in review 2022: systemic lupus erythematosus","volume":"40","author":"Zucchi","year":"2022","journal-title":"Clin. Exp. Rheuma"},{"issue":"1","key":"10.1016\/j.biopha.2023.115198_bib42","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1186\/s13075-021-02664-y","article-title":"Lupus susceptibility region containing CTLA4 rs17268364 functionally reduces CTLA4 expression by binding EWSR1 and correlates IFN-\u03b1 signature","volume":"23","author":"Qi","year":"2021","journal-title":"Arthritis Res. Ther."},{"issue":"18","key":"10.1016\/j.biopha.2023.115198_bib43","doi-asserted-by":"crossref","DOI":"10.3390\/ijms20184505","article-title":"BTLA expression on Th1, Th2 and Th17 effector T-cells of patients with systemic lupus erythematosus is associated with active disease","volume":"20","author":"Oster","year":"2019","journal-title":"Int J. Mol. Sci."},{"issue":"13","key":"10.1016\/j.biopha.2023.115198_bib44","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.99711","article-title":"Defective BTLA functionality is rescued by restoring lipid metabolism in lupus CD4+ T cells","volume":"3","author":"Sawaf","year":"2018","journal-title":"JCI Insight"},{"key":"10.1016\/j.biopha.2023.115198_bib45","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.869197","article-title":"Fatty acid metabolism and T cells in multiple sclerosis","volume":"13","author":"Pompura","year":"2022","journal-title":"Front Immunol."},{"issue":"2","key":"10.1016\/j.biopha.2023.115198_bib46","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1038\/s41584-019-0356-x","article-title":"T cell metabolism: new insights in systemic lupus erythematosus pathogenesis and therapy","volume":"16","author":"Sharabi","year":"2020","journal-title":"Nat. Rev. Rheumatol."},{"issue":"6","key":"10.1016\/j.biopha.2023.115198_bib47","doi-asserted-by":"crossref","DOI":"10.3390\/ijms20061348","article-title":"Fatty acid synthesis and degradation interplay to regulate the oxidative stress in cancer cells","volume":"20","author":"Mikalayeva","year":"2019","journal-title":"Int J. Mol. Sci."},{"issue":"10","key":"10.1016\/j.biopha.2023.115198_bib48","doi-asserted-by":"crossref","DOI":"10.3390\/ijms23105740","article-title":"Short-chain fatty acids augment differentiation and function of human induced regulatory T cells","volume":"23","author":"Hu","year":"2022","journal-title":"Int J. Mol. Sci."},{"key":"10.1016\/j.biopha.2023.115198_bib49","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2020.593103","article-title":"Enhanced fatty acid synthesis leads to subset imbalance and IFN-gamma overproduction in T helper 1 cells","volume":"11","author":"Iwata","year":"2020","journal-title":"Front Immunol."},{"issue":"1","key":"10.1016\/j.biopha.2023.115198_bib50","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1038\/s41385-020-0285-7","article-title":"Targeting cellular fatty acid synthesis limits T helper and innate lymphoid cell function during intestinal inflammation and infection","volume":"14","author":"Mamareli","year":"2021","journal-title":"Mucosal Immunol."},{"key":"10.1016\/j.biopha.2023.115198_bib51","doi-asserted-by":"crossref","first-page":"495","DOI":"10.3389\/fimmu.2018.00495","article-title":"De Novo fatty acid synthesis during mycobacterial infection is a prerequisite for the function of highly proliferative T cells, but not for dendritic cells or macrophages","volume":"9","author":"St\u00fcve","year":"2018","journal-title":"Front Immunol."},{"key":"10.1016\/j.biopha.2023.115198_bib52","doi-asserted-by":"crossref","DOI":"10.1016\/j.metabol.2020.154338","article-title":"The role of peroxisome proliferator-activated receptors (PPAR) in immune responses","volume":"114","author":"Christofides","year":"2021","journal-title":"Metabolism"},{"issue":"4","key":"10.1016\/j.biopha.2023.115198_bib53","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1111\/jcmm.17680","article-title":"Regulatory T cells differentiation in visceral adipose tissues contributes to insulin resistance by regulating JAZF-1\/PPAR-\u03b3 pathway","volume":"27","author":"Meng","year":"2023","journal-title":"J. Cell Mol. Med"},{"issue":"4","key":"10.1016\/j.biopha.2023.115198_bib54","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/j.humimm.2022.01.008","article-title":"Identification of a CD4(+) T cell line with Treg-like activity","volume":"83","author":"Ho","year":"2022","journal-title":"Hum. Immunol."},{"key":"10.1016\/j.biopha.2023.115198_bib55","article-title":"Increased expression of PPAR-\u03b3 modulates monocytes into a M2-like phenotype in SLE patients: an implicative protective mechanism and potential therapeutic strategy of systemic lupus erythematosus","volume":"11","author":"Liu","year":"2020","journal-title":"Front Immunol."},{"issue":"1","key":"10.1016\/j.biopha.2023.115198_bib56","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/j.clim.2013.07.002","article-title":"The peroxisome-proliferator activated receptor-\u03b3 agonist pioglitazone modulates aberrant T cell responses in systemic lupus erythematosus","volume":"149","author":"Zhao","year":"2013","journal-title":"Clinical Immunol."},{"issue":"2","key":"10.1016\/j.biopha.2023.115198_bib57","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1172\/JCI74141","article-title":"Lipids rule: resetting lipid metabolism restores T cell function in systemic lupus erythematosus","volume":"124","author":"Kidani","year":"2014","journal-title":"J. Clin. Invest"},{"key":"10.1016\/j.biopha.2023.115198_bib58","doi-asserted-by":"crossref","first-page":"1027","DOI":"10.3389\/fimmu.2020.01027","article-title":"T cell metabolism: a new perspective on Th17\/Treg cell imbalance in systemic lupus erythematosus","volume":"11","author":"Shan","year":"2020","journal-title":"Front Immunol."},{"issue":"11","key":"10.1016\/j.biopha.2023.115198_bib59","doi-asserted-by":"crossref","DOI":"10.1111\/eci.13012","article-title":"Altered frequency of Th17 and Treg cells in new-onset systemic lupus erythematosus patients","volume":"48","author":"Chen","year":"2018","journal-title":"Eur. J. Clin. Invest"},{"issue":"1","key":"10.1016\/j.biopha.2023.115198_bib60","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1172\/JCI76012","article-title":"Metabolic programming and PDHK1 control CD4+ T cell subsets and inflammation","volume":"125","author":"Gerriets","year":"2015","journal-title":"J. Clinical Investig."},{"issue":"3","key":"10.1016\/j.biopha.2023.115198_bib61","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1016\/j.cmet.2019.07.004","article-title":"Fatty acid metabolites combine with reduced \u03b2 oxidation to activate Th17 inflammation in human type 2 diabetes","volume":"30","author":"Nicholas","year":"2019","journal-title":"Cell Metab."},{"issue":"12","key":"10.1016\/j.biopha.2023.115198_bib62","doi-asserted-by":"crossref","first-page":"1648","DOI":"10.1038\/s42255-021-00489-2","article-title":"Peroxisomal \u03b2-oxidation acts as a sensor for intracellular fatty acids and regulates lipolysis","volume":"3","author":"Ding","year":"2021","journal-title":"Nat. Metab."},{"issue":"5","key":"10.1016\/j.biopha.2023.115198_bib63","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1016\/j.jaci.2005.02.023","article-title":"Adipose tissue, adipokines, and inflammation","volume":"115","author":"Fantuzzi","year":"2005","journal-title":"J. Allergy Clin. Immunol."},{"issue":"2","key":"10.1016\/j.biopha.2023.115198_bib64","doi-asserted-by":"crossref","DOI":"10.3390\/molecules27020334","article-title":"The roles and associated mechanisms of adipokines in development of metabolic syndrome","volume":"27","author":"Kim","year":"2022","journal-title":"Molecules"},{"key":"10.1016\/j.biopha.2023.115198_bib65","doi-asserted-by":"crossref","first-page":"136","DOI":"10.4103\/ijpvm.IJPVM_193_20","article-title":"Adiponectin: role in physiology and pathophysiology","volume":"11","author":"Nguyen","year":"2020","journal-title":"Int J. Prev. Med"},{"issue":"9","key":"10.1016\/j.biopha.2023.115198_bib66","doi-asserted-by":"crossref","first-page":"1619","DOI":"10.1136\/ard.2010.142737","article-title":"High plasma leptin levels confer increased risk of atherosclerosis in women with systemic lupus erythematosus, and are associated with inflammatory oxidised lipids","volume":"70","author":"McMahon","year":"2011","journal-title":"Ann. Rheum. Dis."},{"issue":"11","key":"10.1016\/j.biopha.2023.115198_bib67","doi-asserted-by":"crossref","DOI":"10.3390\/ijms22115446","article-title":"Leptin in atherosclerosis: focus on macrophages, endothelial and smooth muscle cells","volume":"22","author":"Raman","year":"2021","journal-title":"Int J. Mol. Sci."},{"issue":"5","key":"10.1016\/j.biopha.2023.115198_bib68","first-page":"2070","article-title":"Cutting edge: fasting-induced hypoleptinemia expands functional regulatory T cells in systemic lupus erythematosus","volume":"188","author":"Liu","year":"2012","journal-title":"J. Immunol. (Baltim., Md.: 1950)"},{"key":"10.1016\/j.biopha.2023.115198_bib69","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.3389\/fimmu.2018.01055","article-title":"Changes in nutritional status impact immune cell metabolism and function","volume":"9","author":"Alwarawrah","year":"2018","journal-title":"Front Immunol."},{"issue":"8","key":"10.1016\/j.biopha.2023.115198_bib70","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pbio.2005354","article-title":"Symptoms of systemic lupus erythematosus are diagnosed in leptin transgenic pigs","volume":"16","author":"Chen","year":"2018","journal-title":"PLoS Biol."},{"issue":"1","key":"10.1016\/j.biopha.2023.115198_bib71","doi-asserted-by":"crossref","first-page":"5227","DOI":"10.1038\/s41598-019-41534-1","article-title":"Inhibition of IL-17 ameliorates systemic lupus erythematosus in Roquin(san\/san) mice through regulating the balance of TFH cells, GC B cells, Treg and Breg","volume":"9","author":"Lee","year":"2019","journal-title":"Sci. Rep."},{"issue":"11","key":"10.1016\/j.biopha.2023.115198_bib72","doi-asserted-by":"crossref","first-page":"5253","DOI":"10.4049\/jimmunol.1402996","article-title":"Leptin receptor signaling in T cells is required for Th17 differentiation","volume":"194","author":"Reis","year":"2015","journal-title":"J. Immunol."},{"issue":"4","key":"10.1016\/j.biopha.2023.115198_bib73","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1177\/1753425919886643","article-title":"Leptin facilitates the differentiation of Th17 cells from MRL\/Mp-Fas lpr lupus mice by activating NLRP3 inflammasome","volume":"26","author":"Yu","year":"2020","journal-title":"Innate Immun."},{"issue":"2","key":"10.1016\/j.biopha.2023.115198_bib74","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1038\/nrrheum.2016.209","article-title":"Leptin in the interplay of inflammation, metabolism and immune system disorders","volume":"13","author":"Abella","year":"2017","journal-title":"Nat. Rev. Rheumatol."},{"issue":"8","key":"10.1016\/j.biopha.2023.115198_bib75","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1172\/JCI0215693","article-title":"Beneficial effects of leptin on obesity, T cell hyporesponsiveness, and neuroendocrine\/metabolic dysfunction of human congenital leptin deficiency, The","volume":"110","author":"Farooqi","year":"2002","journal-title":"J. Clinical Investig."},{"key":"10.1016\/j.biopha.2023.115198_bib76","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1146\/annurev-immunol-061020-053702","article-title":"Cytokine regulation and function in T cells","volume":"39","author":"Dong","year":"2021","journal-title":"Annu Rev. Immunol."},{"issue":"38","key":"10.1016\/j.biopha.2023.115198_bib77","doi-asserted-by":"crossref","first-page":"10637","DOI":"10.1073\/pnas.1607101113","article-title":"Leptin promotes systemic lupus erythematosus by increasing autoantibody production and inhibiting immune regulation","volume":"113","author":"Louren\u00e7o","year":"2016","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.biopha.2023.115198_bib78","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.cyto.2018.08.002","article-title":"Adipokine interactions promote the pathogenesis of systemic lupus erythematosus","volume":"111","author":"Chougule","year":"2018","journal-title":"Cytokine"},{"issue":"3","key":"10.1016\/j.biopha.2023.115198_bib79","first-page":"458","article-title":"Altered mRNA expression levels of vaspin and adiponectin in peripheral blood mononuclear cells of systemic lupus erythematosus patients","volume":"37","author":"Zhang","year":"2019","journal-title":"Clinical Exp. Rheumatol."},{"issue":"2","key":"10.1016\/j.biopha.2023.115198_bib80","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1007\/s10875-010-9486-2","article-title":"Modulation of lupus phenotype by adiponectin deficiency in autoimmune mouse models","volume":"31","author":"Parker","year":"2011","journal-title":"J. Clinical Immunol."},{"key":"10.1016\/j.biopha.2023.115198_bib81","article-title":"Adiponectin deficiency enhances anti-tumor immunity of CD8(+) T Cells in rhabdomyosarcoma through inhibiting STAT3 activation","volume":"12","author":"Peng","year":"2022","journal-title":"Front Oncol."},{"issue":"4","key":"10.1016\/j.biopha.2023.115198_bib82","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1038\/ni.2005","article-title":"The kinase mTOR regulates the differentiation of helper T cells through the selective activation of signaling by mTORC1 and mTORC2","volume":"12","author":"Delgoffe","year":"2011","journal-title":"Nat. Immunol."},{"issue":"2","key":"10.1016\/j.biopha.2023.115198_bib83","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1038\/nri2888","article-title":"Metabolism, migration and memory in cytotoxic T cells","volume":"11","author":"Finlay","year":"2011","journal-title":"Nat. Rev. Immunol."},{"issue":"6","key":"10.1016\/j.biopha.2023.115198_bib84","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1016\/j.immuni.2011.09.021","article-title":"The transcription factor Myc controls metabolic reprogramming upon T lymphocyte activation","volume":"35","author":"Wang","year":"2011","journal-title":"Immunity"},{"key":"10.1016\/j.biopha.2023.115198_bib85","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/j.coi.2016.09.001","article-title":"T cells in systemic lupus erythematosus","volume":"43","author":"Su\u00e1rez-Fueyo","year":"2016","journal-title":"Curr. Opin. Immunol."},{"issue":"5","key":"10.1016\/j.biopha.2023.115198_bib86","doi-asserted-by":"crossref","first-page":"2730","DOI":"10.4049\/jimmunol.176.5.2730","article-title":"Prolonged TCR\/CD28 engagement drives IL-2-independent T cell clonal expansion through signaling mediated by the mammalian target of rapamycin","volume":"176","author":"Colombetti","year":"2006","journal-title":"J. Immunol."},{"issue":"3","key":"10.1016\/j.biopha.2023.115198_bib87","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1016\/j.smim.2007.02.008","article-title":"mTOR at the crossroads of T cell proliferation and tolerance","volume":"19","author":"Mondino","year":"2007","journal-title":"Semin Immunol."},{"key":"10.1016\/j.biopha.2023.115198_bib88","doi-asserted-by":"crossref","first-page":"13683","DOI":"10.1038\/ncomms13683","article-title":"Fatty acid metabolic reprogramming via mTOR-mediated inductions of PPARgamma directs early activation of T cells","volume":"7","author":"Angela","year":"2016","journal-title":"Nat. Commun."},{"key":"10.1016\/j.biopha.2023.115198_bib89","doi-asserted-by":"crossref","unstructured":"Y. Yin, S.-C. Choi, Z. Xu, D.J. Perry, H. Seay, B.P. Croker, E.S. Sobel, T.M. Brusko, L. Morel, Normalization of CD4 + T cell metabolism reverses lupus, Science Translational Medicine 7(274%U https:\/\/www.science.org\/doi\/10.1126\/scitranslmed.aaa0835) (2015).","DOI":"10.1126\/scitranslmed.aaa0835"},{"issue":"46","key":"10.1016\/j.biopha.2023.115198_bib90","first-page":"173","article-title":"mTOR signaling: a central pathway to pathogenesis in systemic lupus erythematosus?","volume":"9","author":"Fernandez","year":"2010","journal-title":"Discov. Med"},{"issue":"3","key":"10.1016\/j.biopha.2023.115198_bib91","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1016\/j.immuni.2016.08.017","article-title":"mTORC1 and mTORC2 kinase signaling and glucose metabolism drive follicular helper T cell differentiation","volume":"45","author":"Zeng","year":"2016","journal-title":"Immunity"},{"key":"10.1016\/j.biopha.2023.115198_bib92","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2021.111289","article-title":"Rapamycin alleviates renal damage in mice with systemic lupus erythematosus through improving immune response and function","volume":"137","author":"Song","year":"2021","journal-title":"Biomed. Pharmacother."},{"issue":"3","key":"10.1016\/j.biopha.2023.115198_bib93","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1016\/j.jbspin.2012.08.014","article-title":"Do all lupus patients need statins?","volume":"80","author":"Soubrier","year":"2013","journal-title":"Jt. Bone Spine"},{"issue":"10","key":"10.1016\/j.biopha.2023.115198_bib94","doi-asserted-by":"crossref","first-page":"43R","DOI":"10.1093\/glycob\/cwi076","article-title":"Imino sugar inhibitors for treating the lysosomal glycosphingolipidoses","volume":"15","author":"Butters","year":"2005","journal-title":"Glycobiology"},{"issue":"1","key":"10.1016\/j.biopha.2023.115198_bib95","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1177\/0961203311422096","article-title":"Pioglitazone improves the cardiovascular profile in patients with uncomplicated systemic lupus erythematosus: a double-blind randomized clinical trial","volume":"21","author":"Ju\u00e1rez-Rojas","year":"2012","journal-title":"Lupus"},{"issue":"4","key":"10.1016\/j.biopha.2023.115198_bib96","doi-asserted-by":"crossref","DOI":"10.3390\/ijms19041197","article-title":"PPAR agonists and metabolic syndrome: an established role?","volume":"19","author":"Botta","year":"2018","journal-title":"Int J. Mol. Sci."},{"issue":"1","key":"10.1016\/j.biopha.2023.115198_bib97","doi-asserted-by":"crossref","first-page":"23","DOI":"10.4103\/0975-7406.171699","article-title":"Statins and its hepatic effects: newer data, implications, and changing recommendations","volume":"8","author":"Jose","year":"2016","journal-title":"J. Pharm. Bioallied Sci."},{"key":"10.1016\/j.biopha.2023.115198_bib98","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2022.112799","article-title":"Progress in traditional Chinese medicine and natural extracts for the treatment of lupus nephritis","volume":"149","author":"Wang","year":"2022","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.biopha.2023.115198_bib99","doi-asserted-by":"crossref","first-page":"2431617","DOI":"10.1155\/2019\/2431617","article-title":"3\u03b2-acetyloxy-oleanolic acid attenuates pristane-induced lupus nephritis by regulating Th17 differentiation","volume":"2019","author":"Zhou","year":"2019","journal-title":"J. Immunol. Res"},{"issue":"9","key":"10.1016\/j.biopha.2023.115198_bib100","doi-asserted-by":"crossref","first-page":"4748","DOI":"10.1002\/ptr.7105","article-title":"Impact of curcumin on fatty acid metabolism","volume":"35","author":"Nosrati-Oskouie","year":"2021","journal-title":"Phytother. Res"},{"issue":"1","key":"10.1016\/j.biopha.2023.115198_bib101","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1208\/s12248-012-9432-8","article-title":"Therapeutic roles of curcumin: lessons learned from clinical trials","volume":"15","author":"Gupta","year":"2013","journal-title":"AAPS J."},{"issue":"2","key":"10.1016\/j.biopha.2023.115198_bib102","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/j.autrev.2017.11.016","article-title":"Curcumin: A natural modulator of immune cells in systemic lupus erythematosus","volume":"17","author":"Momtazi-Borojeni","year":"2018","journal-title":"Autoimmun. Rev."},{"issue":"4","key":"10.1016\/j.biopha.2023.115198_bib103","doi-asserted-by":"crossref","first-page":"461","DOI":"10.5114\/ceji.2015.56970","article-title":"Treatment of low doses curcumin could modulate Th17\/Treg balance specifically on CD4+ T cell cultures of systemic lupus erythematosus patients","volume":"40","author":"Handono","year":"2015","journal-title":"Cent. Eur. J. Immunol."},{"key":"10.1016\/j.biopha.2023.115198_bib104","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/j.intimp.2019.01.046","article-title":"Curcumin attenuates murine lupus via inhibiting NLRP3 inflammasome","volume":"69","author":"Zhao","year":"2019","journal-title":"Int Immunopharmacol."},{"issue":"1","key":"10.1016\/j.biopha.2023.115198_bib105","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1017\/S0007114512004734","article-title":"Curcumin attenuates lupus nephritis upon interaction with regulatory T cells in New Zealand Black\/White mice","volume":"110","author":"Lee","year":"2013","journal-title":"Br. J. Nutr."},{"issue":"6","key":"10.1016\/j.biopha.2023.115198_bib106","first-page":"2075","article-title":"Curcumin attenuates lupus nephritis in MRL\/lpr mice by suppressing macrophage-secreted B cell activating factor (BAFF)","volume":"12","author":"Li","year":"2019","journal-title":"Int J. Clin. Exp. Pathol."},{"key":"10.1016\/j.biopha.2023.115198_bib107","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1016\/j.phrs.2017.02.008","article-title":"Effects of curcumin on HDL functionality","volume":"119","author":"Ganjali","year":"2017","journal-title":"Pharm. Res"},{"issue":"5","key":"10.1016\/j.biopha.2023.115198_bib108","doi-asserted-by":"crossref","first-page":"1230","DOI":"10.1007\/s43440-021-00227-1","article-title":"Pharmacological properties of baicalin on liver diseases: a narrative review","volume":"73","author":"Yang","year":"2021","journal-title":"Pharm. Rep."},{"key":"10.1016\/j.biopha.2023.115198_bib109","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1186\/1472-6882-12-64","article-title":"Baicalin, a natural compound, promotes regulatory T cell differentiation","volume":"12","author":"Yang","year":"2012","journal-title":"BMC Complement Alter. Med"},{"issue":"12","key":"10.1016\/j.biopha.2023.115198_bib110","doi-asserted-by":"crossref","first-page":"5449","DOI":"10.1007\/s00253-020-10527-w","article-title":"Protective effect of baicalin on the regulation of Treg\/Th17 balance, gut microbiota and short-chain fatty acids in rats with ulcerative colitis","volume":"104","author":"Zhu","year":"2020","journal-title":"Appl. Microbiol Biotechnol."},{"issue":"2","key":"10.1016\/j.biopha.2023.115198_bib111","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1038\/s41419-019-1315-9","article-title":"Baicalin ameliorates lupus autoimmunity by inhibiting differentiation of Tfh cells and inducing expansion of Tfr cells","volume":"10","author":"Yang","year":"2019","journal-title":"Cell Death Dis."},{"issue":"3","key":"10.1016\/j.biopha.2023.115198_bib112","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1007\/s11418-018-1199-5","article-title":"Scutellaria baicalensis regulates FFA metabolism to ameliorate NAFLD through the AMPK-mediated SREBP signaling pathway","volume":"72","author":"Chen","year":"2018","journal-title":"J. Nat. Med"},{"key":"10.1016\/j.biopha.2023.115198_bib113","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/j.biopha.2016.06.046","article-title":"Anti-atherosclerotic potential of baicalin mediated by promoting cholesterol efflux from macrophages via the PPARgamma-LXRalpha-ABCA1\/ABCG1 pathway","volume":"83","author":"He","year":"2016","journal-title":"Biomed. Pharm."},{"issue":"12","key":"10.1016\/j.biopha.2023.115198_bib114","article-title":"Resveratrol possesses protective effects in a pristane-induced lupus mouse model","volume":"9","author":"Wang","year":"2014","journal-title":"PLoS One"},{"issue":"14","key":"10.1016\/j.biopha.2023.115198_bib115","doi-asserted-by":"crossref","first-page":"1611","DOI":"10.1177\/1535370216647181","article-title":"Resveratrol counters systemic lupus erythematosus-associated atherogenicity by normalizing cholesterol efflux","volume":"241","author":"Voloshyna","year":"2016","journal-title":"Exp. Biol. Med (Maywood)"},{"key":"10.1016\/j.biopha.2023.115198_bib116","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/j.ejphar.2014.09.043","article-title":"Celastrol suppresses obesity process via increasing antioxidant capacity and improving lipid metabolism","volume":"744","author":"Wang","year":"2014","journal-title":"Eur. J. Pharmacol."},{"issue":"3","key":"10.1016\/j.biopha.2023.115198_bib117","doi-asserted-by":"crossref","first-page":"237","DOI":"10.5603\/FHC.a2022.0020","article-title":"Celastrol alleviates murine lupus nephritis via inducting CD4+Foxp3+ regulatory T cells","volume":"60","author":"Xiang","year":"2022","journal-title":"Folia Histochem. Et. Cytobiol."},{"issue":"2","key":"10.1016\/j.biopha.2023.115198_bib118","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1016\/j.clim.2015.01.011","article-title":"Celastrol, a Chinese herbal compound, controls autoimmune inflammation by altering the balance of pathogenic and regulatory T cells in the target organ","volume":"157","author":"Astry","year":"2015","journal-title":"Clinical Immunol. (Orlando, Fla. )"},{"issue":"3","key":"10.1016\/j.biopha.2023.115198_bib119","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1016\/j.bbrc.2018.02.163","article-title":"Celastrol mediates Th17 and Treg cell generation via metabolic signaling","volume":"497","author":"Zhang","year":"2018","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"3","key":"10.1016\/j.biopha.2023.115198_bib120","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1016\/j.bbrc.2020.08.076","article-title":"Celastrol suppresses lipid accumulation through LXR\u03b1\/ABCA1 signaling pathway and autophagy in vascular smooth muscle cells","volume":"532","author":"Shi","year":"2020","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"5","key":"10.1016\/j.biopha.2023.115198_bib121","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1002\/biof.1309","article-title":"Mangiferin modulation of metabolism and metabolic syndrome","volume":"42","author":"Fomenko","year":"2016","journal-title":"BioFactors (Oxf., Engl. )"},{"issue":"4","key":"10.1016\/j.biopha.2023.115198_bib122","doi-asserted-by":"crossref","first-page":"1560","DOI":"10.1159\/000494654","article-title":"Mangiferin attenuates murine lupus nephritis by inducing CD4+Foxp3+ regulatory T cells via suppression of mTOR signaling","volume":"50","author":"Liang","year":"2018","journal-title":"Cell Physiol. Biochem."},{"key":"10.1016\/j.biopha.2023.115198_bib123","doi-asserted-by":"crossref","first-page":"10344","DOI":"10.1038\/srep10344","article-title":"Mangiferin supplementation improves serum lipid profiles in overweight patients with hyperlipidemia: a double-blind randomized controlled trial","volume":"5","author":"Na","year":"2015","journal-title":"Sci. Rep."},{"key":"10.1016\/j.biopha.2023.115198_bib124","doi-asserted-by":"crossref","first-page":"2052675","DOI":"10.1155\/2019\/2052675","article-title":"Mangiferin improved palmitate-induced-insulin resistance by promoting free fatty acid metabolism in HepG2 and C2C12 Cells via PPAR\u03b1: mangiferin improved insulin resistance","volume":"2019","author":"Zhang","year":"2019","journal-title":"J. Diabetes Res."},{"issue":"1","key":"10.1016\/j.biopha.2023.115198_bib125","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1093\/advances\/nmy077","article-title":"Protective effects of epigallocatechin-3-gallate from green tea in various kidney diseases","volume":"10","author":"Kanlaya","year":"2019","journal-title":"Adv. Nutr."},{"issue":"2","key":"10.1016\/j.biopha.2023.115198_bib126","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1038\/cmi.2010.1","article-title":"Epigallocatechin-3-gallate (EGCG) attenuates inflammation in MRL\/lpr mouse mesangial cells","volume":"7","author":"Peairs","year":"2010","journal-title":"Cell. Mol. Immunol."},{"issue":"3","key":"10.1016\/j.biopha.2023.115198_bib127","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1016\/j.freeradbiomed.2011.05.016","article-title":"Epigallocatechin-3-gallate prevents lupus nephritis development in mice via enhancing the Nrf2 antioxidant pathway and inhibiting NLRP3 inflammasome activation","volume":"51","author":"Tsai","year":"2011","journal-title":"Free Radic. Biol. Med"},{"issue":"1\u20132","key":"10.1016\/j.biopha.2023.115198_bib128","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.imlet.2013.11.006","article-title":"Epigallocatechin-3-gallate ameliorates both obesity and autoinflammatory arthritis aggravated by obesity by altering the balance among CD4+ T-cell subsets","volume":"157","author":"Byun","year":"2014","journal-title":"Immunol. Lett."},{"issue":"9","key":"10.1016\/j.biopha.2023.115198_bib129","doi-asserted-by":"crossref","DOI":"10.1111\/acel.13199","article-title":"The phytochemical epigallocatechin gallate prolongs the lifespan by improving lipid metabolism, reducing inflammation and oxidative stress in high-fat diet-fed obese rats","volume":"19","author":"Yuan","year":"2020","journal-title":"Aging Cell"},{"key":"10.1016\/j.biopha.2023.115198_bib130","first-page":"1194","article-title":"Antihyperlipidemic compounds from the fruit of piper longum L","volume":"23","author":"Jin","year":"2009"},{"issue":"1","key":"10.1016\/j.biopha.2023.115198_bib131","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/j.imlet.2014.05.001","article-title":"Piperlongumine alleviates lupus nephritis in MRL-Fas(lpr) mice by regulating the frequency of Th17 and regulatory T cells","volume":"161","author":"Yao","year":"2014","journal-title":"Immunol. Lett."},{"key":"10.1016\/j.biopha.2023.115198_bib132","doi-asserted-by":"crossref","first-page":"1172","DOI":"10.3389\/fimmu.2020.01172","article-title":"Piperlongumine acts as an immunosuppressant by exerting prooxidative effects in human T cells resulting in diminished T(H)17 but enhanced T(reg) differentiation","volume":"11","author":"Liang","year":"2020","journal-title":"Front Immunol."},{"key":"10.1016\/j.biopha.2023.115198_bib133","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.32656","article-title":"AMPK signaling to acetyl-CoA carboxylase is required for fasting- and cold-induced appetite but not thermogenesis","volume":"7","author":"Galic","year":"2018","journal-title":"Elife"},{"key":"10.1016\/j.biopha.2023.115198_bib134","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2021.726490","article-title":"Efficacy and safety of metformin use in rheumatoid arthritis: a randomized controlled study","volume":"12","author":"Gharib","year":"2021","journal-title":"Front. Pharmacol."},{"issue":"2","key":"10.1016\/j.biopha.2023.115198_bib135","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1038\/s41584-019-0356-x","article-title":"T cell metabolism: new insights in systemic lupus erythematosus pathogenesis and therapy","volume":"16","author":"Sharabi","year":"2020","journal-title":"Nat. Rev. Rheumatol."},{"issue":"2","key":"10.1016\/j.biopha.2023.115198_bib136","doi-asserted-by":"crossref","DOI":"10.20900\/immunometab20200009","article-title":"T cell Metabolism in Lupus","volume":"2","author":"Vukelic","year":"2020","journal-title":"Immunometabolism"},{"issue":"2","key":"10.1016\/j.biopha.2023.115198_bib137","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1007\/s12026-016-8892-9","article-title":"Dyslipidemia in systemic lupus erythematosus","volume":"65","author":"Szab\u00f3","year":"2017","journal-title":"Immunol. Res."},{"issue":"1","key":"10.1016\/j.biopha.2023.115198_bib138","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1093\/eurheartj\/ehz455","article-title":"2019 ESC\/EAS Guidelines for the management of dyslipidaemias: lipid modification to reduce cardiovascular risk: the task force for the management of dyslipidaemias of the European Society of Cardiology (ESC) and European Atherosclerosis Society (EAS)","volume":"41","author":"Mach","year":"2019","journal-title":"Eur. Heart J."},{"issue":"1","key":"10.1016\/j.biopha.2023.115198_bib139","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1002\/art.41059","article-title":"High-density lipoprotein in lupus: disease biomarkers and potential therapeutic strategy","volume":"72","author":"Kim","year":"2020","journal-title":"Arthritis Rheuma"},{"key":"10.1016\/j.biopha.2023.115198_bib140","article-title":"Causal relationships between rheumatism and dyslipidemia: a two-sample Mendelian randomization study","volume":"13","author":"Zhang","year":"2022","journal-title":"Front Endocrinol. (Lausanne)"}],"container-title":["Biomedicine &amp; Pharmacotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332223009897?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332223009897?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,4]],"date-time":"2026-05-04T07:45:54Z","timestamp":1777880754000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0753332223009897"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,9]]},"references-count":140,"alternative-id":["S0753332223009897"],"URL":"https:\/\/doi.org\/10.1016\/j.biopha.2023.115198","relation":{},"ISSN":["0753-3322"],"issn-type":[{"value":"0753-3322","type":"print"}],"subject":[],"published":{"date-parts":[[2023,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Targeting abnormal lipid metabolism of T cells for systemic lupus erythematosus treatment","name":"articletitle","label":"Article Title"},{"value":"Biomedicine & Pharmacotherapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.biopha.2023.115198","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 The Authors. Published by Elsevier Masson SAS.","name":"copyright","label":"Copyright"}],"article-number":"115198"}}